At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Treatment with tolebrutinib led to greater confirmed disability improvement at 6 months compared with placebo in patients ...

The patient support program Cycle Vita will be available for people with MS taking Bafiertam (monomethyl fumarate) starting ...

Swiss pharma giant Roche RHHBY faced a setback in its efforts to develop a higher dose of multiple sclerosis drug Ocrevus ...

Roche said on Wednesday that a trial testing higher doses of its multiple sclerosis drug Ocrevus did not show an efficacy ...

Biomarker testing also extends beyond cancer care. The science is being used in the treatment of other diseases including ...

“This confirmation by our talented team of researchers demonstrates that fibroblasts can support the regeneration of myelin sheath, marking a potentially significant step in the utilization of a ...

The randomized, double-blind, placebo-controlled trial aims to assess the safety, tolerability, and efficacy of intranasal foralumab in patients with na-SPMS, a form of multiple sclerosis (MS) ...

Multiple sclerosis is a long-term disease that damages the brain and spinal cord. It happens when the immune system attacks ...

Barry Singer, MD, explains why setting realistic expectations about MS treatments is key to managing the disease effectively.

Nearly every modern medical treatment can be traced to research funded by the National Institutes of Health: from ...

In today’s health headlines, March is Multiple Sclerosis Awareness Month. Nearly 400,000 people in the U.S. live with the condition.